BIG PHARMA EARNINGS WATCH: PFIZER, GLAXO SMITH KLINE, BRISTOL MYERS SQUIBB

Big Pharma Companies Continue to Rake in Massive Profits After Three Rounds of Price Hikes During Pandemic

Brand name drug makers Pfizer, Bristol Myers Squibb, and GlaxoSmithKline (GSK) held earnings calls this week for the second quarter of the year. Each of the earnings calls demonstrated pandemic price hikes continued to be profitable for the Big Pharma giants. All three companies beat Wall Street expectations while posting massive sales figures, after having hiked prices on prescription drugs in their portfolios during the pandemic.

Pfizer

Bristol-Myers Squibb
GlaxoSmithKline
The expectation-beating earnings come as the companies have continued to hike prices on prescription drugs and engage in anti-competitive behavior during the pandemic.

Pfizer

Bristol-Myers Squibb
GlaxoSmithKline

Read more on Q2 earnings from Johnson & Johnson, Novartis, and Roche HERE.

Stay tuned this week as we continue to monitor Q2 earnings announcements from Big Pharma.

Learn more about market-based solutions to hold Big Pharma accountable and lower prescription drug prices HERE.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.